| المؤلفون: |
Queirolo P; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Dozin B; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Morabito A; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Banelli B; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.; Department of Health Sciences, University of Genova, Genova, Italy., Piccioli P; Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Fava C; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Leo C; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Carosio R; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Laurent S; Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy., Fontana V; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Ferrucci PF; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Martinoli C; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Cocorocchio E; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Battaglia A; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., Capone M; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., De Galitiis F; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Pagani E; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Marchetti P; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Guida M; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II,'Bari, Italy., Tommasi S; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II,'Bari, Italy., Mandalà M; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Merelli B; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy., Fava P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy., Guidoboni M; Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy., Romani M; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Spagnolo F; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Pistillo MP; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. |
Full Text Finder